Print preview Close
Showing 272 results
Archival DescriptionGrant applications to Health and Welfare Canada for physicians' services in Nova Scotia research projects
Grant applications to Health and Welfare Canada for physicians' services in Nova Scotia research projects
Grant application to Health and Welfare Canada for research on physicians' services in Nova Scotia
Grant application to Health and Welfare Canada for research on physicians' services in Nova Scotia
Grant application and research ethics board correspondence for Innovative HTA methods for chronic progressive disease therapies project
Grant application and research ethics board correspondence for Innovative HTA methods for chronic progressive disease therapies project
Funding applications and reports
Funding applications and reports
First-generation disease-modifying therapy exposure effects on disability burden in ambulatory relapsing-onset MS : fixed effects regression model estimates from 1979-2010 Nova Scotia data
First-generation disease-modifying therapy exposure effects on disability burden in ambulatory relapsing-onset MS : fixed effects regression model estimates from 1979-2010 Nova Scotia data
Final report of the preliminary evaluation of the New Brunswick extra-mural hospital - draft comments and observations by Jim Carter, Laura Freeman and Gordon Ferguson
Final report of the preliminary evaluation of the New Brunswick extra-mural hospital - draft comments and observations by Jim Carter, Laura Freeman and Gordon Ferguson
Extra-mural : the hospital without walls / by Dr. Gordon Ferguson
Extra-mural : the hospital without walls / by Dr. Gordon Ferguson
Extracorporeal shock wave lithotripsy case study presentation transparencies and paper draft of paper
Extracorporeal shock wave lithotripsy case study presentation transparencies and paper draft of paper
Extensive and intensive margins of patient care in physicians' practices - abstract, paper, correpondence and notes
Extensive and intensive margins of patient care in physicians' practices - abstract, paper, correpondence and notes
Experience and earnings of male physicicans in the United States - dissertation
Experience and earnings of male physicicans in the United States - dissertation
Experience and earnings of male physicians : some empirical findings
Experience and earnings of male physicians : some empirical findings
Experience and earnings of male physicians : Initial cohort evidence, paper presented for workshop in application of economics
Experience and earnings of male physicians : Initial cohort evidence, paper presented for workshop in application of economics
Evaluation of health-related quality of life utility measures in patients with multiple sclerosis
Evaluation of health-related quality of life utility measures in patients with multiple sclerosis
Evaluating, funding and managaing new multiple sclerosis drugs in Canada - presentation abstract for International Society for Pharmacoepidemiology Scientific Program Committee meeting
Evaluating, funding and managaing new multiple sclerosis drugs in Canada - presentation abstract for International Society for Pharmacoepidemiology Scientific Program Committee meeting
Evaluating secondary prevention in chronic disease - presentation to International Society for Technology Assessment in Health Care
Evaluating secondary prevention in chronic disease - presentation to International Society for Technology Assessment in Health Care
European Committee for Treatment and Research in Multiple Sclerosis - abstracts and posters submitted by Dalhousie MS Research Group
European Committee for Treatment and Research in Multiple Sclerosis - abstracts and posters submitted by Dalhousie MS Research Group
Estimating effectiveness and cost-effectiveness of secondary prevention therapies for chronic progressive diseases using longitudinal observational data : a case study for multiple sclerosis - International Society for Pharmacoeconomics & Outcomes Research abstract
Estimating effectiveness and cost-effectiveness of secondary prevention therapies for chronic progressive diseases using longitudinal observational data : a case study for multiple sclerosis - International Society for Pharmacoeconomics & Outcomes Research abstract
Estimates of MS disability progression natural history speed before and after applying censoring bias reduction methods to observational Nova Scotia EDSS-clinic-visit 1979-2010 data
Estimates of MS disability progression natural history speed before and after applying censoring bias reduction methods to observational Nova Scotia EDSS-clinic-visit 1979-2010 data
Estimates of MS disability progression natural history speed before and after applying censoring bias reduction methods to observational Nova Scotia EDSS-clinic-visit 1979-2010 data
Estimates of MS disability progression natural history speed before and after applying censoring bias reduction methods to observational Nova Scotia EDSS-clinic-visit 1979-2010 data
Employment records and contracts
Employment records and contracts
Emails and notes regarding natural history progression of multiple sclerosis regression model analysis
Emails and notes regarding natural history progression of multiple sclerosis regression model analysis
Email between Sarah Kirby and Murray Brown regarding modelling for research on drug efficacy in delaying disability progression in relapsing remitting onset MS
Email between Sarah Kirby and Murray Brown regarding modelling for research on drug efficacy in delaying disability progression in relapsing remitting onset MS
Effects of capping global expenditures and individual practice incomes in Nova Scotia
Effects of capping global expenditures and individual practice incomes in Nova Scotia
Effects of a global budget for physician services on claiming patterns to Workers Compensation Board
Effects of a global budget for physician services on claiming patterns to Workers Compensation Board
Effectiveness of disease-modifying MS drugs in delaying progression in the 'real world' - draft abstracts, working paper, tables and notes
Effectiveness of disease-modifying MS drugs in delaying progression in the 'real world' - draft abstracts, working paper, tables and notes
Effectiveness of disease modifying agents in multiple sclerosis : a longitudinal population based comparison - presentation, notes and tables
Effectiveness of disease modifying agents in multiple sclerosis : a longitudinal population based comparison - presentation, notes and tables
Effectiveness and cost-effectiveness of new multiple sclerosis drugs the "real world" : final report to Health Policy Research Program, Health Canada
Effectiveness and cost-effectiveness of new multiple sclerosis drugs the "real world" : final report to Health Policy Research Program, Health Canada
Effectiveness and cost-effectiveness of new multiple sclerosis drugs in the 'real world' - draft reports with corrections
Effectiveness and cost-effectiveness of new multiple sclerosis drugs in the 'real world' - draft reports with corrections
Effectiveness and cost-effectiveness of new multiple sclerosis drugs in the real world - correspondence re. data transfer/analysis request, data tables, and 2001 proposal to Health Policy Research Program
Effectiveness and cost-effectiveness of new multiple sclerosis drugs in the real world - correspondence re. data transfer/analysis request, data tables, and 2001 proposal to Health Policy Research Program
Effectiveness and cost-effectiveness of new multiple sclerosis drugs in the 'real world'
Effectiveness and cost-effectiveness of new multiple sclerosis drugs in the 'real world'
Effectiveness and cost-effectiveness of new multiple sclerosis drugs in the "real world"
Effectiveness and cost-effectiveness of new multiple sclerosis drugs in the "real world"
Effectiveness and cost-effectiveness of new muliple sclerosis drugs in the "real world" - research grant application to Multiple Sclerosis Society of Canada and correspondence regarding accounts and research ethics
Effectiveness and cost-effectiveness of new muliple sclerosis drugs in the "real world" - research grant application to Multiple Sclerosis Society of Canada and correspondence regarding accounts and research ethics
Effectiveness and cost-effectiveness of new drugs on multiple sclerosis disability progression in the "real world" : final report
Effectiveness and cost-effectiveness of new drugs on multiple sclerosis disability progression in the "real world" : final report
Effectiveness and cost-effectiveness of new drugs on multiple sclerosis disability progression in the "real world"
Effectiveness and cost-effectiveness of new drugs on multiple sclerosis disability progression in the "real world"
Effectiveness and cost-effectiveness of disease modifying therapies that slow disability progression in relapsing remitting and secondary progressive multiple sclerosis : tables and graphs
Effectiveness and cost-effectiveness of disease modifying therapies that slow disability progression in relapsing remitting and secondary progressive multiple sclerosis : tables and graphs
EDSS survival analysis notes, life-table survival function estimate
EDSS survival analysis notes, life-table survival function estimate
EDSS natural history atlas : multiple sclerosis disability progression in Nova Scotia, 1979-2004
EDSS natural history atlas : multiple sclerosis disability progression in Nova Scotia, 1979-2004
Economic evaluation of Extracorporeal Shock Wave Lithotripsy (ESWL) in treating kidney stones - draft reports, correpondence, tables, study questionnaire, secondary literature, presentation slides
Economic evaluation of Extracorporeal Shock Wave Lithotripsy (ESWL) in treating kidney stones - draft reports, correpondence, tables, study questionnaire, secondary literature, presentation slides
Economic consequences of chronic illness - presentation notes
Economic consequences of chronic illness - presentation notes
Do Kaplan-Meier models underestimate MS disability progression speed when populated with observational data - Community Health and Epidemiology Series presentation, synopsis, notes, data
Do Kaplan-Meier models underestimate MS disability progression speed when populated with observational data - Community Health and Epidemiology Series presentation, synopsis, notes, data
Do cost-effective programs reduce costs? - notes
Do cost-effective programs reduce costs? - notes
Disease-modifying drugs and multiple sclerosis research notes, drafts and data tables
Disease-modifying drugs and multiple sclerosis research notes, drafts and data tables
Disability progression in multiple sclerosis is faster than observed
Disability progression in multiple sclerosis is faster than observed
Disability progression in MS measured by means, medians and survival distribution functions - submission abstract to International Society For Pharmacoeconomics and Outcomes Research congress, notes, tables, appendices, correspondence and data tables
Disability progression in MS measured by means, medians and survival distribution functions - submission abstract to International Society For Pharmacoeconomics and Outcomes Research congress, notes, tables, appendices, correspondence and data tables
Description of EMH data files (on 3 1/2 inch disks)
Description of EMH data files (on 3 1/2 inch disks)
Dalhousie/Capital Health appointments
Dalhousie/Capital Health appointments
Dalhousie University computer output files on Nova Scotia physician earnings and population estimates
Dalhousie University computer output files on Nova Scotia physician earnings and population estimates
Dalhousie MS Research Unit annual report
Dalhousie MS Research Unit annual report
Dalhousie MS Research Group meeting minutes
Dalhousie MS Research Group meeting minutes
Dalhousie MS research group evaluation studies 1994-2009
Dalhousie MS research group evaluation studies 1994-2009
Results 151 to 200 of 272